Literature DB >> 19497374

Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals.

V Markov1, A Krug, S Krach, C Whitney, T Eggermann, K Zerres, T Stöcker, N J Shah, M M Nöthen, J Treutlein, M Rietschel, T Kircher.   

Abstract

Genetic variation in dysbindin 1 (DTNBP1) gene region tagged by SNP rs1018381 exhibits a linkage with cognitive deficits in patients with schizophrenia and healthy subjects. Language production deficits are core features of schizophrenia with more impairment in semantic than lexical verbal fluency tasks. We investigated the link between brain activation and DTNBP1 SNP rs1018381 during semantic verbal fluency task in a German healthy population. 46 healthy subjects genotyped for SNP rs1018381 status were divided in heterozygous risk-allele carriers (T/C) and homozygous non-carriers (C/C). Neural correlates of semantic verbal fluency were investigated with functional magnetic resonance imaging (fMRI). Stronger right hemispherical brain activation in anterior cingulate gyrus (BA 24), superior (BA 22, 38) and middle (BA 21) temporal gyrus was observed in the carriers compared to non-carriers. Brain activations occurred in the absence of task performance differences. No significant correlations were found between personality traits and brain activation differences. The results point to an influence of genetic variation in DTNBP1 gene region tagged by SNP rs1018381 on neural correlates of language production. Carriers may exhibit higher processing efforts to reach the same behavioural performance as non-carriers as reflected in activation of schizophrenia-related regions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497374     DOI: 10.1016/j.neuroimage.2009.05.067

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  12 in total

Review 1.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

2.  Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.

Authors:  Ariana P Mullin; Madhumala K Sadanandappa; Wenpei Ma; Dion K Dickman; Krishnaswamy VijayRaghavan; Mani Ramaswami; Subhabrata Sanyal; Victor Faundez
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

Review 3.  Intermediate phenotypes in psychiatric disorders.

Authors:  Roberta Rasetti; Daniel R Weinberger
Journal:  Curr Opin Genet Dev       Date:  2011-03-04       Impact factor: 5.578

4.  Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Authors:  Jennifer Larimore; Stephanie A Zlatic; Avanti Gokhale; Karine Tornieri; Kaela S Singleton; Ariana P Mullin; Junxia Tang; Konrad Talbot; Victor Faundez
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

5.  Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.

Authors:  Jian-Ping Zhang; Katherine E Burdick; Todd Lencz; Anil K Malhotra
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

6.  The effect of neurogranin on neural correlates of episodic memory encoding and retrieval.

Authors:  Axel Krug; Sören Krach; Andreas Jansen; Vanessa Nieratschker; Stephanie H Witt; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Schizophr Bull       Date:  2011-07-28       Impact factor: 9.306

7.  The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.

Authors:  Moogeh Baharnoori; Cali Bartholomeusz; Aurelie A Boucher; Lisa Buchy; Christopher Chaddock; Bonga Chiliza; Melanie Föcking; Alex Fornito; Juan A Gallego; Hiroaki Hori; Gisele Huf; Gul A Jabbar; Shi Hyun Kang; Yousri El Kissi; Jessica Merchán-Naranjo; Gemma Modinos; Nashaat A M Abdel-Fadeel; Anna-Karin Neubeck; Hsiao Piau Ng; Gabriela Novak; Olasunmbo O Owolabi; Diana P Prata; Naren P Rao; Igor Riecansky; Darryl C Smith; Renan P Souza; Renate Thienel; Hanan D Trotman; Hiroyuki Uchida; Kristen A Woodberry; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2010-10-08       Impact factor: 4.939

8.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

9.  The effects of a DTNBP1 gene variant on attention networks: an fMRI study.

Authors:  Markus Thimm; Axel Krug; Thilo Kellermann; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Behav Brain Funct       Date:  2010-09-16       Impact factor: 3.759

10.  A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects.

Authors:  Heidelore Raum; Bruno Dietsche; Arne Nagels; Stephanie H Witt; Marcella Rietschel; Tilo Kircher; Axel Krug
Journal:  Hum Brain Mapp       Date:  2014-09-13       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.